Hot Topics
$5.35 million award in insurance company bad faith case
– Read the case summary
"Job-bias cases surge in Colorado, feds say"
– The Denver Post
"FedEx Sued For Not Letting Workers Clock In On Time"
"U.S. Supreme Court upholds right to recover compensation from drug companies for injuries"
– "Wyeth v. Levine Opinion"
– "Court allows drug label lawsuit"
– Wyeth Press Release
"Gadolinium law suits picks up pace"
– Missouri Lawyers Weekly
Wal-Mart Class Action Wage Lawsuits
"Attorney Michael Burg Leads the Hunt for Culprits in Economic Meltdown"
Janet Abaray Spearheads Class Action Suit Against Bengals
Explosion Accidents:
"Pooch alive after
Breck blast"
– Denver Post
"Baxter to Proceed with Recall of Remaining Heparin Sodium Vial Products"
– FDA
Yamaha Rhino ATV Rollover Accidents
and Injuries
"UBS Hit by
Another Lawsuit"
– Ben Levinsohn, BusinessWeek
"Hedge Funds
Frozen Shut"
– Matthew Goldstein, BusinessWeek
"MRI Contrast Can Cause Disease – Gadolinium Blamed
For Problems"
– Dayle Cedars
7News, Denver, CO
Results
$5,350,000
Jury awards a Burg Simpson client $5.35 million for Bad Faith Breach of Insurance Contract.
$1,300,000
Jury award to Englewood company to total more than $1 million for breach of fiduciary duties in Shareholder Class Action Case.
$690,000,000
Global settlement with Eli Lilly and Company regarding its product Zyprexa negotiated by a plaintiffs' attorney group including members of Burg Simpson.
$5,800,000
Hines, et al, vs. Cody Gas Company, et al: verdict for injuries, damages, losses from gas explosion.
CLICK HERE FOR MORE INFORMATION
Our Offices
40 Inverness Drive East
Denver, CO 80112
Phone: 303.792.5595
Fax: 303.708.0527
WYOMING OFFICE
Phone: 307.527.7891
Fax: 307.527.7897
OHIO OFFICE
Phone: 513.852.5600
Fax: 513.852.5611
ARIZONA OFFICE
Phone: 602.508.6040
Home > Defective Drugs > Nephrogenic Systemic Fibrosis (NSF)
Gadolinium Dyes and Nephrogenic Systemic Fibrosis Claims Attorneys
In Ohio, Colorado and Nationwide
Gadolinium is a contrast agent that helps distinguish between normal and abnormal tissue in the body when used with magnetic resonance imaging (MRI) and/or CT scans. Gadolinium was approved for use in 1988.
"Gadolinium law suits picks up pace"
– Correy E. Stephenson, Missouri Lawyers Weekly
Click to read the report done by Dayle Cedars, News7, Denver, CO:
"MRI Contrast Can Cause Disease – Gadolinium Blamed For Problems"
or click to view the video
Click to read the report done by Mike TeSelle, KCRA 3, Sacramento, CA:
"Some Kidney Patients Suffer MRI Poisoning
– Dye Containing Gadolinium Blamed For Problems"
Click to view our video about "Gadolinium Dyes"
Click to view our video about "Nephrogenic Systemic Fibrosis"
View our NSF brochure for more information
Click to read the report done by Correy E. Stephenson, Lawyers USA:
"Gadolinium litigation heats up"
Nephrogenic systemic fibrosis (NSF), described in 2000, is an emerging systemic disorder characterized by widespread tissue fibrosis. NFS was not known to the medical community before March 1997 and some medical authors suggest that the sudden occurrence of the disease in the last 8 years makes it likely that a new agent or technique of examination causes it. Currently, there is no effective treatment available for NSF.
Based on recent research, NSF occurs only in patients with advanced or in end stage kidney disease and is strongly related to the use of gadolinium dyes for MRI scans. At this time, there are no known cases of NSF in patients with normal kidney function.
In a pivotal study in 2006 conducted by Dr. T. Grobner it was noted that 5 of their 9 patients diagnosed with NSF had received a MRI involving use of Omniscan Contrast Dye, a gadolinium-based contrast agent manufactured by GE. This study was followed shortly by other studies and case reports showing a similar strong association.
The Little-Known Debilitating and Deadly Danger of MRIs
Frequently Asked Questions About
Nephrogenic Systemic Fibrosis (NSF) Lawsuits
If you believe you have developed NSF, we strongly advise you to contact your physician for an examination which may involve a skin biopsy. If you are, in fact, diagnosed with NSF then you may want to talk with an attorney in order to protect your legal rights. Burg Simpson is here to help you. We take cases on a contingency basis, which means that we are paid only if we bring about a recovery for our clients. We have already retained national experts in assist us with your case. Contact us now to schedule your free confidential consultation with our experienced defective product attorneys.
For more information about this topic read "Gadolinium detected in NSF patients body tissues" written by John M. Restaino, Jr., DPM, J.D.
¹Grobner T. Gadolinium - a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis? Nephrol Dial Transplant. 2006 Apr;21(4):1104-8. (Grobner, 2006). Erratum 2006 Jun;21(6):1745.
Return to the Defective Drugs Section
